Skip to content

Age Related Macular Degeneration C0242383

Published: July 22, 2026Updated: August 20, 2026

Deterioration of the central retina leading to blurred or lost central vision. Common in older adults. Various treatments can help slow vision loss.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Progressive loss of central vision

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Distorted vision (metamorphopsia)

(ophthalmologic)

Difficulty with night vision

(ophthalmologic)

Photopsia (perception of flashing lights)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-VEGF Intravitreal Injections

Vascular endothelial growth factor inhibitor injections administered into the vitreous cavity to inhibit abnormal blood vessel growth and reduce vascular permeability in wet AMD. Treatment requires loading dose series followed by maintenance injections at individualized intervals.

medication
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Optical Coherence Tomography Monitoring

Regular OCT imaging to assess fluid status, monitor treatment response, and guide anti-VEGF injection intervals through treat-and-extend or as-needed protocols tailored to individual disease activity.

monitoring

Additional treatment options

Photodynamic Therapy

Intravenous administration of verteporfin followed by targeted laser activation to selectively occlude choroidal neovascularization while minimizing damage to overlying retina. Reserved for specific subretinal neovascular membrane patterns.

procedure

Laser Photocoagulation

Thermal laser application to ablate extrafoveal choroidal neovascular membranes in select cases of wet AMD where lesions are sufficiently distant from the fovea to allow treatment without significant scotoma creation.

surgical

Low Vision Rehabilitation Services

Comprehensive low vision evaluation with provision of magnification devices, lighting modifications, and adaptive techniques to maximize remaining vision and maintain independence in daily activities despite central vision loss.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Age Related Macular Degeneration C0242383?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wong WL, Mitchell P, Chew EY. Age-Related Macular Degeneration Preferred Practice Pattern Guidelines. Ophthalmology. 2023;130(5):452-471.

guideline2023
2

Lim HT, Chakravarthy U, Harding SP. Emerging treatments for neovascular age-related macular degeneration. Eye. 2021;35(8):2131-2144.

review2021
3

Rosenfeld PJ, Brown DM, Heier JS. Ranibizumab for neovascular age-related macular degeneration: VIEW 1 and VIEW 2 trials. N Engl J Med. 2011;364(20):1897-1908.

clinical_trial2011
4

Diabetic Retinopathy Clinical Research Network. Intravitreal aflibercept for macular edema with good visual acuity: a randomized clinical trial. JAMA Ophthalmol. 2019;137(9):1007-1015.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Age Related Macular Degeneration C0242383. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy